Thomas Jefferson University

Jefferson Digital Commons
Phase 1

Class of 2022

1-2020

Evaluating the Impact of KardiaMobile on Healthcare
Expenditures
Christopher Gerace, MPH
Thomas Jefferson University, christopher.gerace@jefferson.edu

Daniel Frisch, MD
Thomas Jefferson University, daniel.frisch@jefferson.edu

Follow this and additional works at: https://jdc.jefferson.edu/si_dh_2022_phase1
Part of the Cardiology Commons, and the Health Information Technology Commons

Let us know how access to this document benefits you
Recommended Citation
Gerace, MPH, Christopher and Frisch, MD, Daniel, "Evaluating the Impact of KardiaMobile on
Healthcare Expenditures" (2020). Phase 1. Paper 14.
https://jdc.jefferson.edu/si_dh_2022_phase1/14
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Phase 1 by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.

Title: Evaluating the Impact of KardiaMobile on Healthcare Expenditures
Christopher Gerace MPH, Daniel Frisch MD
Background:
KardiaMobile is a mobile ECG device, with smartphone connectivity, that is able to detect atrial
fibrillation (a-fib). The device captures a 30 second reading and an algorithm differentiates a-fib
from sinus rhythm. The mobile application can alert the user to an a-fib reading and also send
the ECG output to their personal physician. By monitoring a-fib without accessing traditional
care, KardiaMobile has the potential to reduce healthcare costs for patients with a-fib. This
study looked to evaluate the effect of KardiaMobile on healthcare utilization for patients with
suspected or diagnosed a-fib and who see a clinical cardiac electrophysiologist.
Methods:
To measure utilization, we conducted a retrospective chart review. A database was created
documenting the number of times patients went to office visits, the emergency department, were
admitted to the hospital, had a cardiac procedure done, called/messaged the office, used
cardiac monitors, and had cardiac imaging conducted. Each of these events were counted for
one year prior to the first time the patient used KardiaMobile, and up to one year after they
began using KardiaMobile.
Results:
Comparing the pre-Kardia and current-Kardia timeframes, we observed a minor overall
difference in healthcare utilization. Looking at individual points of contact with the healthcare
system, there was a reduction in emergency department visits.
Conclusion:
The use of KardiaMobile in patients with diagnosed or suspected a-fib was not associated with
any difference in overall healthcare utilization. The data show that there was a significant
reduction in higher acuity points of care--notably emergency department visits.

